Profile data is unavailable for this security.
About the company
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS is a Turkey-based company, which is s a biotechnology company operating in accordance with ISO 9001, ISO 13485 and 98/79/EC Total Quality Systems. The Company's main activities are to develop and produce Real-Time Polymerase Chain Reaction (Real-Time PCR) kits, and to create a complete solution with automatic nucleic acid isolation devices and Real-Time PCR Systems. The main goals of the entity are to reduce Turkey's foreign dependency in molecular diagnostics and biotechnology and to gain success in the global market by developing and producing molecular genetic products.
- Revenue in TRY (TTM)627.84m
- Net income in TRY-304.14m
- Incorporated2010
- Employees247.00
- LocationAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AEgitim Mah. Kasap Ismail Sk. No:10/23ISTANBUL 34722TurkeyTUR
- Phone+90 2 163300455
- Fax+90 2 163300042
- Websitehttps://www.anatoliageneworks.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascelia Pharma AB | 0.00 | -373.25m | 1.89bn | 11.00 | -- | 3.92 | -- | -- | -0.693 | -0.693 | 0.00 | 0.7777 | 0.00 | -- | -- | -- | -60.31 | -54.24 | -85.44 | -64.44 | -- | -- | -- | -- | -- | -31.70 | 0.0097 | -- | -- | -- | 4.72 | -- | -32.17 | -- |
| Skinbiotherapeutics PLC | 276.50m | -41.51m | 1.91bn | 41.00 | -- | 3.40 | -- | 6.91 | -0.0032 | -0.0032 | 0.0204 | 0.0364 | 0.5349 | 2.80 | 4.81 | 113,125.60 | -8.03 | -44.16 | -9.90 | -53.32 | 61.65 | -- | -15.01 | -175.65 | 4.29 | -12.21 | 0.0954 | -- | 283.74 | -- | 75.79 | -- | 16.61 | -- |
| Poolbeg Pharma PLC | 0.00 | -340.40m | 1.95bn | 10.00 | -- | 2.75 | -- | -- | -0.0114 | -0.0114 | 0.00 | 0.0171 | 0.00 | -- | -- | 0.00 | -45.01 | -- | -46.84 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -47.29 | -- | -- | -- |
| Fermentalg SA | 662.62m | -598.19m | 2.07bn | 63.00 | -- | 1.41 | -- | 3.13 | -0.1242 | -0.1242 | 0.1353 | 0.3156 | 0.2472 | 7.91 | 3.29 | 199,734.40 | -17.09 | -18.10 | -21.17 | -20.59 | 20.94 | 25.51 | -69.14 | -147.66 | 1.83 | -- | 0.2368 | -- | 183.32 | 43.52 | 8.99 | -- | -4.91 | -- |
| ImmuPharma PLC | 0.00 | -234.56m | 2.09bn | 6.00 | -- | 103.74 | -- | -- | -0.0089 | -0.0089 | 0.00 | 0.0007 | 0.00 | -- | -- | 0.00 | -139.44 | -89.81 | -259.88 | -121.17 | -- | -- | -- | -9,895.75 | -- | -2.76 | 0.00 | -- | -- | -- | 15.00 | -- | -56.60 | -- |
| Sequana Medical NV | 0.00 | -2.69bn | 2.14bn | 48.00 | -- | -- | -- | -- | -1.24 | -1.24 | 0.00 | -0.6848 | 0.00 | 1.61 | -- | 0.00 | -408.93 | -201.76 | -- | -- | -- | -427.70 | -- | -4,902.24 | 0.1559 | -0.5006 | 18.59 | -- | -85.19 | -35.84 | -37.13 | -- | -22.17 | -- |
| Herantis Pharma Oyj | 0.00 | -282.68m | 2.47bn | 13.00 | -- | 27.28 | -- | -- | -0.2417 | -0.2417 | 0.00 | 0.0726 | 0.00 | -- | -- | 0.00 | -124.50 | -81.63 | -166.61 | -107.95 | -- | -- | -- | -- | -- | -17.91 | 0.6101 | -- | -- | -- | -1,865.03 | -- | -- | -- |
| Anatolia TaniveBytklj Unli Ar Ge SiveTiA | 627.84m | -304.14m | 2.56bn | 247.00 | -- | 1.53 | -- | 4.08 | -1.38 | -1.38 | 2.85 | 7.63 | 0.3282 | 0.7324 | 4.92 | 2,815,434.00 | -15.90 | 5.77 | -17.08 | 6.10 | 63.69 | 80.17 | -48.44 | 15.31 | 2.09 | -- | 0.0869 | -- | 54.06 | 91.00 | -10.92 | -- | 96.35 | -- |
| Medivir AB | 19.50m | -380.91m | 2.59bn | 10.00 | -- | 2.02 | -- | 132.66 | -0.6789 | -0.6789 | 0.0348 | 0.5831 | 0.0238 | -- | 0.9374 | 398,400.00 | -46.44 | -31.75 | -69.67 | -38.14 | -- | -- | -1,953.24 | -740.12 | -- | -70.04 | 0.00 | -- | -54.36 | -16.77 | -38.06 | -- | -- | -- |
| Pangaea Oncology SA | 773.95m | -71.04m | 2.94bn | 168.00 | -- | 2.77 | 40.91 | 3.80 | -0.0411 | -0.0382 | 0.4148 | 0.5955 | 0.5291 | 8.19 | 2.40 | 90,489.63 | -4.59 | -8.46 | -6.16 | -10.68 | 65.21 | 65.18 | -8.67 | -29.07 | 1.64 | -- | 0.1539 | -- | 93.14 | 33.89 | 68.36 | -- | 250.70 | -- |
| Theranexus SA | 0.00 | -152.29m | 2.95bn | 10.00 | -- | -- | -- | -- | -0.3641 | -0.3641 | 0.00 | -0.1923 | 0.00 | -- | -- | 0.00 | -66.82 | -44.47 | -148.89 | -50.85 | -- | -- | -- | -- | -- | -37.71 | 2.90 | -- | -- | -- | 74.15 | -- | -56.53 | -- |
Data as of Feb 13 2026. Currency figures normalised to Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A's reporting currency: Turkish Lira TRY
0.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Union Bancaire Priv�e, UBP SA (UK)as of 25 Jan 2024 | 230.39k | 0.11% |
| Polunin Capital Partners Ltd.as of 30 Jun 2025 | 128.33k | 0.06% |
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
